Peri-arterial mast cells in coronary atheroma and thrombosis.

[1]  E. Benditt,et al.  5-Hydroxytryptamine in Mast Cells.∗ , 1955, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[2]  J. B. Duguid.  Diet and coronary disease. , 1954, Lancet.

[3]  E. Nikkila,et al.  The blood heparinoid substances in human atherosclerosis. , 1952, Scandinavian journal of clinical and laboratory investigation.

[4]  J. Gofman,et al.  Blood Lipids and Human Atherosclerosis: II. The Influence of Heparin upon Lipoprotein Metabolism , 1951, Circulation.

[5]  J. Gofman,et al.  Lipoproteins in atherosclerosis. , 1951, The American journal of medicine.

[6]  B. Sylvén,et al.  Analysis of the native heparin-lipoprotein complex including the identification of a heparin complement (heparin co-factor) obtained from extracts of tissue mast cells. , 1951, Biochimica et biophysica acta.

[7]  B. Hellstrom,et al.  Numerical distribution of mast cells in the human skin and heart. , 1950, Acta anatomica.

[8]  L. Jaques.  The determination of heparin in blood. , 1949, Acta haematologica.

[9]  P. Hughesdon.  Two uses of uranyl nitrate. , 1949, Journal. Royal Microscopical Society.

[10]  G. Paff,et al.  THE MORPHOLOGY AND BEHAVIOR OF NEOPLASTIC MAST CELLS CULTIVATED IN VITRO , 1947, The Journal of experimental medicine.